Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about industries/pharmaceuticals/and/biotech

Recent news which mentions industries/pharmaceuticals/and/biotech

< Previous 1 2 3 4 Next >
Ebvia Announces Positive Results Published in Nature for TMPRSS2 Inhibitor for the Prevention and Treatment of COVID-19
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Longwood Fund Announces Longwood Healthcare Leaders, a Web Conference for Industry Leaders, on May 4-5, 2022
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Tadgh Prendeville to Assume the Role of President and CEO at Regis Technologies, Inc.
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Vivacitas Oncology Appoints Harvard Professor of Medicine Dr. David Reardon, MD to the Company's Neuro-Oncology Medical Advisory Board
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Philogen SpA - Notice of Full Year 2021 Results
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Almac Pharma Services Expands Its Unique Ultra-Low Temperature Solutions for Advanced Therapy Medicinal Products
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Evidence of Manipulated Lyme Disease Diagnostics Presented to Suffolk County, NY Health Commissioner
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology's Solid Tumor Medical Advisory Board
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
CDMOs Recognized for Service and Leadership
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
OliLux Biosciences Kickstarts a Partnership With the UCSF Center for Tuberculosis and the Rapid Research in Diagnostics Development (R2D2) for TB Network
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease
Tickers UTHR
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Scailyte Hosts Webinar About Supervised Learning of Disease-Associated Cell States and Dynamics
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Bob Discordia Joins CaaMTech as Chief Scientific Officer
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Philogen Receives Authorisation to Initiate New Study in France to Evaluate Nidlegy™ in Several Non-Melanoma Skin Cancers
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
K3-Innovations Has Retained Biopharmaceutical Development Veteran Jim Baker to Drive Expansion of Its Clinical Research Offerings
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Vivacitas Oncology to Present at the 2022 BIO CEO & Investor Conference
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Nemysis Ltd Announces Appointment of Antonino Santoro as Adviser for Scientific Affairs
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Nexien BioPharma Engages Dr. Benedikt Schoser as Advisor
Tickers NXEN
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Gb Sciences and Michigan State University Researchers Have Identified the Complicated Truth Behind the Opportunity for an Effective Cannabinoid-Based Coronavirus Treatment
Tickers GBLX
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Vivacitas Oncology Strengthens Its Neuro-Oncology Board With World-Class Advisor Dr. Katherine Peters, MD, PhD, FAAN
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Premier Pharmacy Services Adds KRYSTEXXA® (Pegloticase) to Rare Disease Portfolio
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Explora BioLabs Launches Preclinical Vivarium Model in Seattle
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Atrial Fibrilillation Study by NativeCardio and the Texas Heart Institute Show Ultra-Low Cardioversion is Possible
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Cellvera Receives $20M Purchase Order for COVID-19 Oral Antiviral Avigan®
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
AiPharma Announces Corporate Rebrand, Changing Its Name to Cellvera
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Vivacitas Oncology to Present a Poster on AR-67 at the 3rd Annual Glioblastoma Drug Development Summit
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Dr. Erkut Borazanci, MD, Joins Vivacitas Oncology's Pancreatic Medical Advisory Board
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Vivacitas Oncology to Present AR-67 at the Biotech Showcase Investor Conference
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Halo Biosciences Participating in BIO @ JPM and BIOTECH SHOWCASE™ During J.P. Morgan Week 2022
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
Vivacitas Oncology Welcomes Dr. Jai Grewal, MD, and Expands Its Neuro-Oncology Advisory Board
Tags industries/pharmaceuticals/and/biotech
From Latest Press Releases from Newswire.com
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.